Intelligence · Patents
Patents expiring in 2030
Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.
- Patents
- 880
Quick answer
880 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7767677
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
granted -
US 7767784
Methods for preparing polymeric reagents and compositions of polymeric reagents
granted -
US 7767717
Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
granted -
US 7767816
Azaindoles useful as inhibitors of janus kinases
granted -
US 7771732
Polymer network compositions and associated methods
granted -
US 7771963
Methods for determining efficacy of chemotherapeutic agents
granted -
US 7772188
Methods and compositions for the treatment of gastrointestinal disorders
granted -
US 7772370
Antifungal polypeptides
granted -
US 7772387
Oligonucleotides comprising a modified or non-natural nucleobase
granted -
US 7772219
Methods of hormonal treatment utilizing extended cycle contraceptive regimens
granted -
US 7772200
iRNA agents targeted to the Rho-A gene
granted -
US 7772366
Inhibitors of interleukin-1β converting enzyme
granted -
US 7771729
Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors
granted -
US 7772192
Compositions and methods for treatment of disease with acetylated disaccharides
granted -
US 7772239
Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists
granted -
US 7772250
Compounds
granted -
US 7772230
Chroman compound, processes for its preparation, and its pharmaceutical use
granted -
US 7772259
1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
granted -
US 7771707
Abuse-deterrent drug formulations
granted -
US 7772434
Crystalline form of a β2 adrenergic receptor agonist
granted -
US 7771956
Method for detecting the presence of a phospholipid
granted -
US 7772271
Methods for treating hepatitis C
granted -
US 7771715
Recombinant vector expressing multiple costimulatory molecules and uses thereof
granted -
US 7776365
Article with skin protecting and moisturizing compound
granted -
US 7776521
Coronavirus isolated from humans
granted -
US 7776816
Preserving hypoxic tissue
granted -
US 7776548
Endocytotic pathway delivery vehicle for targeting drugs and antibodies to prostate and other tissues
granted -
US 7776564
Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use
granted -
US 7776593
Hes6 as a marker of pancreatic endocrine cells
granted -
US 7777027
Purified beta glucan composition
granted -
US 7776905
Modulators of ATP-binding cassette transporters
granted -
US 7777034
Crystalline ammonium salts of rosuvastatin
granted -
US 7777047
Indole compound
granted -
US 7777069
Prodrugs of carbamate inhibitors of IMPDH
granted -
US 7776537
Method of preparing a PRRS virus vaccine
granted -
US 7776320
Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
granted -
US 7776823
Human cathelicidin antimicrobial peptides
granted -
US 7777000
Anti-viral activity of cathelicidin peptides
granted -
US 7777019
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
granted -
US 7777036
Heterocyclic derivatives and their use as therapeutic agents
granted -
US 7777077
Dual-acting antihypertensive agents
granted -
US 7776908
Wortmannin analogs and methods of using same
granted -
US 7776827
Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome
granted -
US 7776883
Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)
granted -
US 7776879
Quinuclidine carbamate derivatives and their use as M3 antagonists
granted -
US 7776887
Processes and intermediates
granted -
US 7776847
Benzisothiazoles useful for treating or preventing HCV infection
granted -
US 7776337
Bacteriocins and novel bacterial strains
granted
Frequently asked questions
How many pharma patents expire in 2030?
880 published patents in our USPTO index have expiration dates falling in calendar year 2030.